Publication | Open Access
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
380
Citations
5
References
2023
Year
ObesityMetabolic SyndromeFood IntoleranceWeight LossGlucagon-like Peptide 1Gastrointestinal PharmacologyDiabetesPharmacologyGastroenterologyObesity ManagementPharmacotherapyDatabase StudyEndocrinologyMedicineGastrointestinal Peptide Hormone
This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastrointestinal adverse events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1